Related Experiment Video
Updated: Aug 13, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Abstract:
In phlebology, an anticoagulant treatment is usually called for in the fight against thrombosis. The favourable short-term development of most phlebites means that an anticoagulant treatment should not be used unless there are serious risks involved in the various complications observed. This treatment may therefore be used, on condition that diagnosis is certain, that the risks involved are serious enough; the least restrictive, least expensive form of treatment is preferable, provided that it is as effective, of course; the conditions of applications should be scrupulously upheld: no contraindications, the cooperation of the patient, quality of the biological controls etc. If these conditions are respected, the anticoagulant treatment combines efficiency and safety to a degree which places it foremost among anti-thrombotic methods, after physiotherapy.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

